Regeneron and Bayer's efforts to defend their lucrative eye disease therapy Eylea from competition have been boosted by FDA approval of a new high-dose formulation of the drug. The US regulator ...

Novartis is launching a head-to-head trial of its experimental brolucizumab therapy for age-related macular degeneration (AMD) against Bayer/Regeneron’s Eylea, the market leader. The TALON trial ...

Manmohan Singh’s success lay in making a decisive and historic shift towards the West. It was also audacious, in my book even more so than the 1991 reform, given how little support it had within ...

You can register to vote online or on paper. Paper forms are available at public libraries and many offices, including the Department of Elections.Register Here ...